Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 tefinostat study in chronic myelomonocytic leukaemia
ISRCTN17394489Phase 2Completed
- Sponsor
- Cardiff University
- Start
- Sep 2015
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of tefinostat in chronic myelomonocytic leukemia (CMML), sponsored by Cardiff University. Primary endpoints: Safety and tolerability and Overall clinical response rate. Started Sep 2015; status: completed.
02
Drugs
tefinostat
03
Conditions
chronic myelomonocytic leukemia (CMML)
Beyond the preview
Go deeper on ISRCTN17394489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN17394489.